STAT3 and hepatocellular carcinoma: KD of p66Shc could obviously inhibit the development and progression of HCC in vitro and in vivo through modulating Signal Transducer And Activator Of Transcription 3 (STAT3) signaling pathway-mediated regulation of tumor microenvironment29–31.